163 related articles for article (PubMed ID: 33196599)
1. Subclassification of BI-RADS 4 Magnetic Resonance Lesions: A Systematic Review and Meta-Analysis.
Li J; Zheng H; Cai W; Wang Y; Zhang H; Liao M
J Comput Assist Tomogr; 2020; 44(6):914-920. PubMed ID: 33196599
[TBL] [Abstract][Full Text] [Related]
2. Differential Diagnosis of Breast Category 3 and 4 Nodules Through BI-RADS Classification in Conjunction with Shear Wave Elastography.
Wang M; Yang Z; Liu C; Yan J; Zhang W; Sun J; Cui G
Ultrasound Med Biol; 2017 Mar; 43(3):601-606. PubMed ID: 27988221
[TBL] [Abstract][Full Text] [Related]
3. Subcategory classifications of Breast Imaging and Data System (BI-RADS) category 4 lesions on MRI.
Honda M; Kataoka M; Kawaguchi K; Iima M; Miyake KK; Kishimoto AO; Ota R; Ohashi A; Toi M; Nakamoto Y
Jpn J Radiol; 2021 Jan; 39(1):56-65. PubMed ID: 32870440
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Diagnostic Accuracy and Efficiency of Categories 4 and 5 of the Second Edition of the BI-RADS Ultrasound Lexicon in Diagnosing Breast Lesions.
Zou X; Wang J; Lan X; Lin Q; Han F; Liu L; Li A
Ultrasound Med Biol; 2016 Sep; 42(9):2065-71. PubMed ID: 27262521
[TBL] [Abstract][Full Text] [Related]
5. Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
Spinelli Varella MA; Teixeira da Cruz J; Rauber A; Varella IS; Fleck JF; Moreira LF
Clin Breast Cancer; 2018 Aug; 18(4):e507-e511. PubMed ID: 29066139
[TBL] [Abstract][Full Text] [Related]
6. A multiparametric classification system for lesions detected by breast magnetic resonance imaging.
Istomin A; Masarwah A; Okuma H; Sutela A; Vanninen R; Sudah M
Eur J Radiol; 2020 Nov; 132():109322. PubMed ID: 33045483
[TBL] [Abstract][Full Text] [Related]
7. Subcategorization of Ultrasonographic BI-RADS Category 4: Assessment of Diagnostic Accuracy in Diagnosing Breast Lesions and Influence of Clinical Factors on Positive Predictive Value.
He P; Cui LG; Chen W; Yang RL
Ultrasound Med Biol; 2019 May; 45(5):1253-1258. PubMed ID: 30799123
[TBL] [Abstract][Full Text] [Related]
8. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of combined BI-RADS analysis and Nakagami statistics of ultrasound echoes in the diagnosis of breast lesions.
Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Roszkowska-Purska K; Nowicki A; Jakubowski W
Clin Radiol; 2017 Apr; 72(4):339.e7-339.e15. PubMed ID: 28038779
[TBL] [Abstract][Full Text] [Related]
10. Utilizing size-based thresholds of stiffness gradient to reclassify BI-RADS category 3-4b lesions increases diagnostic performance.
Shang J; Ruan LT; Wang YY; Zhang XJ; Dang Y; Liu B; Wang WL; Song Y; Chang SJ
Clin Radiol; 2019 Apr; 74(4):306-313. PubMed ID: 30755314
[TBL] [Abstract][Full Text] [Related]
11. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
Bennani-Baiti B; Dietzel M; Baltzer PA
PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
[TBL] [Abstract][Full Text] [Related]
12. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
[TBL] [Abstract][Full Text] [Related]
13. The value of MRI for downgrading of breast suspicious lesions detected on ultrasound.
Xie Z; Xu W; Zhang H; Li L; An Y; Mao G
BMC Med Imaging; 2023 Jun; 23(1):72. PubMed ID: 37271827
[TBL] [Abstract][Full Text] [Related]
14. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis.
Spick C; Bickel H; Polanec SH; Baltzer PA
Eur Radiol; 2018 May; 28(5):1919-1928. PubMed ID: 29168006
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of MRI radiomics-based diagnosis for BI-RADS 4 breast lesions.
Lin J; Zheng H; Jia Q; Shi J; Wang S; Wang J; Ge M
J Cancer Res Clin Oncol; 2024 May; 150(5):254. PubMed ID: 38748373
[TBL] [Abstract][Full Text] [Related]
16. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
[TBL] [Abstract][Full Text] [Related]
17. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
[TBL] [Abstract][Full Text] [Related]
18. Value of the US BI-RADS final assessment following mastectomy: BI-RADS 4 and 5 lesions.
Gweon HM; Son EJ; Youk JH; Kim JA; Chung J
Acta Radiol; 2012 Apr; 53(3):255-60. PubMed ID: 22302210
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study.
Sanders MA; Roland L; Sahoo S
Breast J; 2010; 16(1):28-31. PubMed ID: 19929890
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
